Marc Riedl

Title(s)Professor Of Clinical, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCLAClinical Immunology & Allergy Fellowship
    UCLA David Geffen School of Medicine, Los Angeles, CAMSClinical Research
    University of Chicago - Pritzker School of MedicineMD

    Collapse Overview 
    Collapse Overview
    Dr. Riedl is Clinical Director of the US HAEA Angiodema Center at the UC San Diego. His professional focus is on angiodema conditions and primary immunodeficiency, and clinical pharmacology.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications. Allergy Asthma Proc. 2021 Nov 01; 42(6):506-514. Veronez CL, Christiansen SC, Smith TD, Riedl MA, Zuraw BL. PMID: 34871158.
      View in: PubMed   Mentions:
    2. Optimization of care for patients with hereditary angioedema living in rural areas. Ann Allergy Asthma Immunol. 2021 Oct 07. Riedl MA, Johnston DT, Anderson J, Meadows JA, Soteres D, LeBlanc SB, Wedner HJ, Lang DM. PMID: 34628006.
      View in: PubMed   Mentions:    Fields:    
    3. Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet J Rare Dis. 2021 Jul 28; 16(1):329. Lumry WR, Zuraw B, Cicardi M, Craig T, Anderson J, Banerji A, Bernstein JA, Caballero T, Farkas H, Gower RG, Keith PK, Levy DS, Li HH, Magerl M, Manning M, Riedl MA, Lawo JP, Prusty S, Machnig T, Longhurst H, COMPACT Investigators. PMID: 34321052; PMCID: PMC8317315.
      View in: PubMed   Mentions:    Fields:    
    4. Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study. Allergy. 2021 Jul 21. Banerji A, Bernstein JA, Johnston DT, Lumry WR, Magerl M, Maurer M, Martinez-Saguer I, Zanichelli A, Hao J, Inhaber N, Yu M, Riedl MA, HELP OLE Investigators. PMID: 34287942.
      View in: PubMed   Mentions: 2     Fields:    
    5. Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. Clin Exp Allergy. 2021 Oct; 51(10):1391-1395. Johnston DT, Busse PJ, Riedl MA, Maurer M, Anderson J, Nurse C, Inhaber N, Yu M, Banerji A, HELP Study Investigators. PMID: 34166549.
      View in: PubMed   Mentions: 1     Fields:    
    6. The Road to Better Urticaria and Angioedema Management. J Allergy Clin Immunol Pract. 2021 06; 9(6):2243-2244. Riedl M, Maurer M. PMID: 34112474.
      View in: PubMed   Mentions:
    7. Consensus on treatment goals in hereditary angioedema: A global Delphi initiative. J Allergy Clin Immunol. 2021 May 25. Maurer M, Aygören-Pürsün E, Banerji A, Bernstein JA, Balle Boysen H, Busse PJ, Bygum A, Caballero T, Castaldo AJ, Christiansen SC, Craig T, Farkas H, Grumach AS, Hide M, Katelaris CH, Li HH, Longhurst H, Lumry WR, Magerl M, Martinez-Saguer I, Riedl MA, Zhi Y, Zuraw B. PMID: 34048855.
      View in: PubMed   Mentions:    Fields:    
    8. Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape. Allergy Asthma Proc. 2021 05 01; 42(3):S1-S3. Banerji A, Riedl MA, Craig TJ, Radojicic C. PMID: 33980326.
      View in: PubMed   Mentions: 1     Fields:    
    9. Patient perspectives on the treatment burden of injectable medication for hereditary angioedema. Allergy Asthma Proc. 2021 05 01; 42(3):S4-S10. Radojicic C, Riedl MA, Craig TJ, Best JM, Rosselli J, Hahn R, Banerji A. PMID: 33980327.
      View in: PubMed   Mentions: 1     Fields:    
    10. Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden. Allergy Asthma Proc. 2021 05 01; 42(3):S11-S16. Craig TJ, Banerji A, Riedl MA, Best JM, Rosselli J, Hahn R, Radojicic C. PMID: 33980328.
      View in: PubMed   Mentions: 1     Fields:    
    11. Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs. Allergy Asthma Proc. 2021 05 01; 42(3):S17-S25. Riedl MA, Craig TJ, Banerji A, Aggarwal K, Best JM, Rosselli J, Hahn R, Radojicic C. PMID: 33980329.
      View in: PubMed   Mentions: 1     Fields:    
    12. Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report. Allergy Asthma Clin Immunol. 2021 Apr 19; 17(1):40. Bork K, Anderson JT, Caballero T, Craig T, Johnston DT, Li HH, Longhurst HJ, Radojicic C, Riedl MA. PMID: 33875020; PMCID: PMC8056543.
      View in: PubMed   Mentions:
    13. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet J Rare Dis. 2021 02 15; 16(1):86. Lumry WR, Zuraw B, Cicardi M, Craig T, Anderson J, Banerji A, Bernstein JA, Caballero T, Farkas H, Gower RG, Keith PK, Levy DS, Li HH, Magerl M, Manning M, Riedl MA, Lawo JP, Prusty S, Machnig T, Longhurst H, on behalf of the COMPACT Investigators. PMID: 33588897; PMCID: PMC7885603.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study. Allergy. 2021 04; 76(4):1188-1198. Lumry WR, Weller K, Magerl M, Banerji A, Longhurst HJ, Riedl MA, Lewis HB, Lu P, Devercelli G, Jain G, Maurer M, HELP Study Investigators. PMID: 33258114; PMCID: PMC8247292.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    15. Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies. Allergy Asthma Proc. 2021 01 21; 42(1):22-29. Johnston DT, Henry Li H, Craig TJ, Bernstein JA, Anderson J, Joseph K, Riedl MA. PMID: 33349293.
      View in: PubMed   Mentions: 3     Fields:    
    16. A roadmap for optimal care of the patient with hereditary angioedema. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S01-S02. Castaldo AJ, Riedl MA, Settipane RA, Bellanti JA. PMID: 33109316.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Hereditary angioedema and shared decision making. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S55-S60. Settipane RA, Bukstein DA, Riedl MA. PMID: 33109329.
      View in: PubMed   Mentions:
    18. Current medical management of hereditary angioedema: Follow-up survey of US physicians. Ann Allergy Asthma Immunol. 2021 03; 126(3):264-272. Riedl MA, Banerji A, Gower R. PMID: 33122123.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial. J Allergy Clin Immunol. 2021 07; 148(1):164-172.e9. Zuraw B, Lumry WR, Johnston DT, Aygören-Pürsün E, Banerji A, Bernstein JA, Christiansen SC, Jacobs JS, Sitz KV, Gower RG, Gagnon R, Wedner HJ, Kinaciyan T, Hakl R, Hanzlíková J, Anderson JT, McNeil DL, Fritz SB, Yang WH, Tachdjian R, Busse PJ, Craig TJ, Li HH, Farkas H, Best JM, Clemons D, Cornpropst M, Dobo SM, Iocca HA, Kargl D, Nagy E, Murray SC, Collis P, Sheridan WP, Maurer M, Riedl MA. PMID: 33098856.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    20. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 01; 9(1):132-150.e3. Busse PJ, Christiansen SC, Riedl MA, Banerji A, Bernstein JA, Castaldo AJ, Craig T, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Zuraw BL. PMID: 32898710.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. Allergy. 2020 11; 75(11):2879-2887. Riedl MA, Maurer M, Bernstein JA, Banerji A, Longhurst HJ, Li HH, Lu P, Hao J, Juethner S, Lumry WR, HELP Investigators. PMID: 32452549; PMCID: PMC7689768.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Association Between Self-Reported Dental Hygiene Practices and Dental Procedure-Related Recurrent Angioedema Attacks in HAE Subjects: A Multicenter Survey. J Allergy Clin Immunol Pract. 2020 10; 8(9):3162-3169.e5. Singh U, Lumry WR, Busse P, Wedner HJ, Banerji A, Craig TJ, Li HH, Tachdjian R, Jacobs JS, Riedl MA, Davis-Lorton M, Christiansen SC, Zuraw BL, Bernstein JA. PMID: 32534150.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema. Ann Allergy Asthma Immunol. 2020 09; 125(3):334-340.e1. Bernstein JA, Schwartz L, Yang W, Baker J, Anderson J, Farkas H, Aygören-Pürsün E, Bygum A, Jacobs I, Feuersenger H, Pragst I, Riedl MA. PMID: 32445670.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence. Allergy. 2020 08; 75(8):2115-2123. Maurer M, Aberer W, Agondi R, Al-Ahmad M, Al-Nesf MA, Ansotegui I, Arnaout R, Arruda LK, Asero R, Aygören-Pürsün E, Banerji A, Bauer A, Ben-Shoshan M, Berardi A, Bernstein JA, Betschel S, Bindslev-Jensen C, Bizjak M, Boccon-Gibod I, Bork K, Bouillet L, Boysen HB, Brodszki N, Broesby-Olsen S, Busse P, Buttgereit T, Bygum A, Caballero T, Campos RA, Cancian M, Cherrez-Ojeda I, Cohn DM, Costa C, Craig T, Criado PR, Criado RF, Csuka D, Dissemond J, Du-Thanh A, Ensina LF, Ertas R, Fabiani JE, Fantini C, Farkas H, Ferrucci SM, Figueras-Nart I, Fili NL, Fomina D, Fukunaga A, Gelincik A, Giménez-Arnau A, Godse K, Gompels M, Gonçalo M, Gotua M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Ilina N, Inomata N, Jakob T, Josviack DO, Kang HR, Kaplan A, Kasperska-Zajac A, Katelaris C, Kessel A, Kleinheinz A, Kocatürk E, Košnik M, Krasowska D, Kulthanan K, Kumaran MS, Larco Sousa JI, Longhurst HJ, Lumry W, MacGinnitie A, Magerl M, Makris MP, Malbrán A, Marsland A, Martinez-Saguer I, Medina IV, Meshkova R, Metz M, Nasr I, Nicolay J, Nishigori C, Ohsawa I, Özyurt K, Papadopoulos NG, Parisi CAS, Peter JG, Pfützner W, Popov T, Prior N, Ramon GD, Reich A, Reshef A, Riedl MA, Ritchie B, Röckmann-Helmbach H, Rudenko M, Salman A, Sanchez-Borges M, Schmid-Grendelmeier P, Serpa FS, Serra-Baldrich E, Sheikh FR, Smith W, Soria A, Staubach P, Steiner UC, Stobiecki M, Sussman G, Tagka A, Thomsen SF, Treudler R, Valle S, van Doorn M, Varga L, Vázquez DO, Wagner N, Wang L, Weber-Chrysochoou C, Ye YM, Zalewska-Janowska A, Zanichelli A, Zhao Z, Zhi Y, Zuberbier T, Zwiener RD, Castaldo A. PMID: 32248571.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review. J Allergy Clin Immunol Pract. 2020 06; 8(6):1875-1880.e3. Brooks JP, Radojicic C, Riedl MA, Newcomer SD, Banerji A, Hsu FI. PMID: 32251736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial. Allergy Asthma Clin Immunol. 2020; 16:8. Levy DS, Farkas H, Riedl MA, Hsu FI, Brooks JP, Cicardi M, Feuersenger H, Pragst I, Reshef A. PMID: 32042283; PMCID: PMC7001333.
      View in: PubMed   Mentions: 2  
    27. Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. Allergy Asthma Clin Immunol. 2019; 15:49. Li HH, Zuraw B, Longhurst HJ, Cicardi M, Bork K, Baker J, Lumry W, Bernstein J, Manning M, Levy D, Riedl MA, Feuersenger H, Prusty S, Pragst I, Machnig T, Craig T, COMPACT Investigators. PMID: 31485239; PMCID: PMC6714075.
      View in: PubMed   Mentions: 1  
    28. Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies. BioDrugs. 2019 Feb; 33(1):33-43. Busse PJ, Farkas H, Banerji A, Lumry WR, Longhurst HJ, Sexton DJ, Riedl MA. PMID: 30539362; PMCID: PMC6373397.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1610-1618.e4. Lumry WR, Martinez-Saguer I, Yang WH, Bernstein JA, Jacobs J, Moldovan D, Riedl MA, Johnston DT, Li HH, Tang Y, Schranz J, Lu P, Vardi M, Farkas H, SAHARA study group. PMID: 30682573.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):2035-2038. Craig T, Lumry W, Cicardi M, Zuraw B, Bernstein JA, Anderson J, Jacobs J, Riedl MA, Manning ME, Banerji A, Gower RG, Caballero T, Farkas H, Feuersenger H, Jacobs I, Machnig T, Longhurst H, COMPACT Investigators. PMID: 30660873.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    31. Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. JAMA. 2018 11 27; 320(20):2108-2121. Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL, Busse PJ, Anderson J, Magerl M, Martinez-Saguer I, Davis-Lorton M, Zanichelli A, Li HH, Craig T, Jacobs J, Johnston DT, Shapiro R, Yang WH, Lumry WR, Manning ME, Schwartz LB, Shennak M, Soteres D, Zaragoza-Urdaz RH, Gierer S, Smith AM, Tachdjian R, Wedner HJ, Hebert J, Rehman SM, Staubach P, Schranz J, Baptista J, Nothaft W, Maurer M, HELP Investigators. PMID: 30480729; PMCID: PMC6583584.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    32. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States. Orphanet J Rare Dis. 2018 10 12; 13(1):180. Riedl MA, Banerji A, Manning ME, Burrell E, Joshi N, Patel D, Machnig T, Tai MH, Watson DJ. PMID: 30314518; PMCID: PMC6186115.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema. Clin Exp Allergy. 2018 10; 48(10):1325-1332. Pawaskar D, Tortorici MA, Zuraw B, Craig T, Cicardi M, Longhurst H, Li HH, Lumry WR, Martinez-Saguer I, Jacobs J, Bernstein JA, Riedl MA, Katelaris CH, Keith PK, Feussner A, Sidhu J. PMID: 29998524.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    34. Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema. Clin Exp Allergy. 2018 11; 48(11):1429-1438. Lara-Marquez ML, Christiansen SC, Riedl MA, Herschbach J, Zuraw BL. PMID: 29957871.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency. Ann Allergy Asthma Immunol. 2018 12; 121(6):673-679. Craig T, Busse P, Gower RG, Johnston DT, Kashkin JM, Li HH, Lumry WR, Riedl MA, Soteres D. PMID: 30056152.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks. Allergy Asthma Proc. 2018 Sep 28; 39(5):359-364. Baker JW, Bernstein JA, Harper JR, Relan A, Riedl MA. PMID: 29954477.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Hereditary angioedema from the patient's perspective: A follow-up patient survey. Allergy Asthma Proc. 2018 May 01; 39(3):212-223. Banerji A, Li Y, Busse P, Riedl MA, Holtzman NS, Li HH, Davis-Lorton M, Bernstein JA, Frank M, Castaldo AJ, Long J, Zuraw B, Lumry W, Christiansen S. PMID: 29669666; PMCID: PMC5911511.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    38. C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply. Lancet. 2018 04 07; 391(10128):1356. Riedl MA, Relan A, Harper JR, Cicardi M. PMID: 29636270.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1733-1741.e3. Lumry WR, Craig T, Zuraw B, Longhurst H, Baker J, Li HH, Bernstein JA, Anderson J, Riedl MA, Manning ME, Keith PK, Levy DS, Caballero T, Banerji A, Gower RG, Farkas H, Lawo JP, Pragst I, Machnig T, Watson DJ. PMID: 29391286.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    40. An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension. Clin Transl Allergy. 2017; 7:36. Riedl MA, Bernstein JA, Craig T, Banerji A, Magerl M, Cicardi M, Longhurst HJ, Shennak MM, Yang WH, Schranz J, Baptista J, Busse PJ. PMID: 29043014; PMCID: PMC5629784.
      View in: PubMed   Mentions: 7  
    41. Vedolizumab in Patients With Common Variable Immune Deficiency and Gut Inflammation. Am J Gastroenterol. 2017 10; 112(10):1621. Boland BS, Riedl MA, Valasek MA, Crowe SE, Sandborn WJ. PMID: 28978958; PMCID: PMC6389596.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement. Allergy Asthma Proc. 2017 Nov 13; 38(6):462-466. Riedl MA, Li HH, Cicardi M, Harper JR, Relan A. PMID: 28903805.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    43. Emerging Therapies in Hereditary Angioedema. Immunol Allergy Clin North Am. 2017 08; 37(3):585-595. Chen M, Riedl MA. PMID: 28687111; PMCID: PMC5585075.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    44. Angioedema: Challenges and Insights. Immunol Allergy Clin North Am. 2017 08; 37(3):xv-xvi. Riedl MA. PMID: 28687115.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. Lancet. 2017 Sep 30; 390(10102):1595-1602. Riedl MA, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M. PMID: 28754491.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    46. Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation. Ann Allergy Asthma Immunol. 2017 09; 119(3):258-261. Geng B, Eastman JJ, Mori K, Braskett M, Riedl MA. PMID: 28743423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States. Ann Allergy Asthma Immunol. 2017 07; 119(1):59-64. Riedl MA, Banerji A, Busse PJ, Johnston DT, Davis-Lorton MA, Patel S, Parr H, Chiao J, Watson DJ, Burrell E, Machnig T. PMID: 28668241.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    48. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med. 2017 03 23; 376(12):1131-1140. Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, Li HH, Reshef A, Bonner J, Bernstein JA, Anderson J, Lumry WR, Farkas H, Katelaris CH, Sussman GL, Jacobs J, Riedl M, Manning ME, Hebert J, Keith PK, Kivity S, Neri S, Levy DS, Baeza ML, Nathan R, Schwartz LB, Caballero T, Yang W, Crisan I, Hernandez MD, Hussain I, Tarzi M, Ritchie B, Králícková P, Guilarte M, Rehman SM, Banerji A, Gower RG, Bensen-Kennedy D, Edelman J, Feuersenger H, Lawo JP, Machnig T, Pawaskar D, Pragst I, Zuraw BL, COMPACT Investigators. PMID: 28328347.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    49. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017 Mar 01; 8(1):13-19. Craig T, Shapiro R, Vegh A, Baker JW, Bernstein JA, Busse P, Magerl M, Martinez-Saguer I, Riedl MA, Lumry W, Williams-Herman D, Edelman J, Feuersenger H, Machnig T, Rojavin M. PMID: 28381322; PMCID: PMC5380447.
      View in: PubMed   Mentions: 3  
    50. Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. 2017 02 23; 376(8):717-728. Banerji A, Busse P, Shennak M, Lumry W, Davis-Lorton M, Wedner HJ, Jacobs J, Baker J, Bernstein JA, Lockey R, Li HH, Craig T, Cicardi M, Riedl M, Al-Ghazawi A, Soo C, Iarrobino R, Sexton DJ, TenHoor C, Kenniston JA, Faucette R, Still JG, Kushner H, Mensah R, Stevens C, Biedenkapp JC, Chyung Y, Adelman B. PMID: 28225674.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    51. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1091-1097. Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl MA. PMID: 28202404.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    52. Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry. Ann Allergy Asthma Immunol. 2017 01; 118(1):110-112. Magerl M, Frank M, Lumry W, Bernstein J, Busse P, Craig T, Martinez-Saguer I, Riedl MA, Shapiro R, Edelman J, Williams-Herman D, Wood DN, Feuersenger H, Rojavin M, Berinert Registry Investigators. PMID: 27865714.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    53. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility. J Allergy Clin Immunol Pract. 2017 Mar - Apr; 5(2):442-447.e1. Otani IM, Lumry WR, Hurwitz S, Li HH, Craig TJ, Holtzman NS, Iandoli MI, Tucker J, Riedl MA, Zuraw BL, Banerji A. PMID: 27818136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. Allergy Asthma Proc. 2016 Nov; 37(6):489-500. Riedl MA, Lumry WR, Li HH, Banerji A, Bernstein JA, Ba M, Bjrkander J, Magerl M, Maurer M, Rockich K, Chen H, Schranz J. PMID: 27931305.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    55. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):128-134.e4. Otani IM, Christiansen SC, Busse P, Camargo CA, Zuraw BL, Riedl MA, Banerji A. PMID: 27665386.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):963-71. Riedl MA, Bygum A, Lumry W, Magerl M, Bernstein JA, Busse P, Craig T, Frank MM, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M, Berinert Registry investigators. PMID: 27286778.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    57. Cases of acquired C1 inhibitor deficiency treated with rituximab. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):987-8. Doshi A, Tse K, Riedl M, Zuraw B, Christiansen S. PMID: 27130715.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema. Clin Drug Investig. 2015 Jul; 35(7):407-17. Riedl M. PMID: 26091744; PMCID: PMC4488495.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol. 2015 Jul; 115(1):33-8. Geng B, Thakor A, Clayton E, Finkas L, Riedl MA. PMID: 25959032.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    60. Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedema. Allergy Asthma Proc. 2015 May-Jun; 36(3):206-12. Riedl MA, Lumry WR, Busse P, Levy H, Steele T, Dayno J, Li HH. PMID: 25803135; PMCID: PMC4405600.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    61. Before and after, the impact of available on-demand treatment for HAE. Allergy Asthma Proc. 2015 Mar-Apr; 36(2):145-50. Christiansen SC, Bygum A, Banerji A, Busse P, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank MM, Castaldo A, Long JF, Riedl M, Zuraw BL. PMID: 25715243.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    62. Critical appraisal of androgen use in hereditary angioedema: a systematic review. Ann Allergy Asthma Immunol. 2015 Apr; 114(4):281-288.e7. Riedl MA. PMID: 25707325.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    63. Current medical management of hereditary angioedema: follow-up survey of US physicians. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):220-7. Riedl MA, Banerji A, Gower R. PMID: 25609328.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. The therapeutic landscape for hereditary angioedema: more change on the horizon? Ann Allergy Asthma Immunol. 2014 Oct; 113(4):337-8. Riedl MA. PMID: 25256026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Reply: To PMID 24565612. J Allergy Clin Immunol Pract. 2014 Mar-Apr; 2(2):239-40. Riedl MA. PMID: 24607059.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2014 Feb; 112(2):163-169.e1. Riedl MA, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M, Study 1310 Investigators. PMID: 24468257.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCTClinical Trials
    67. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema. Am J Rhinol Allergy. 2013 Nov-Dec; 27(6):517-21. Riedl MA, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME. PMID: 24274230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):458-67. Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Riedl M, US Hereditary Angioedema Association Medical Advisory Board. PMID: 24565617.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    69. Creating a comprehensive treatment plan for hereditary angioedema. Immunol Allergy Clin North Am. 2013 Nov; 33(4):471-85. Riedl MA. PMID: 24176212.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. Hereditary angioedema with normal C1-INH (HAE type III). J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):427-32. Riedl MA. PMID: 24565612.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Ann Allergy Asthma Immunol. 2013 Apr; 110(4):295-9. Riedl MA, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL. PMID: 23535096.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    72. Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women. Allergy Asthma Proc. 2013 Mar-Apr; 34(2):162-9. Baker JW, Craig TJ, Riedl MA, Banerji A, Fitts D, Kalfus IN, Uknis ME. PMID: 23484892.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    73. HAE update: special considerations in the female patient with hereditary angioedema. Allergy Asthma Proc. 2013 Jan-Feb; 34(1):13-8. Geng B, Riedl MA. PMID: 23406930.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    74. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012 Nov-Dec; 33 Suppl 1:S145-56. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, Kaplan A, Riedl M, Kirkpatrick C, Magerl M, Drouet C, Cicardi M. PMID: 23394603.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    75. Allergic inflammation in the human lower respiratory tract affected by exposure to diesel exhaust. Res Rep Health Eff Inst. 2012 Feb; (165):5-43; discussion 45-64. Riedl MA, Diaz-Sanchez D, Linn WS, Gong H, Clark KW, Effros RM, Miller JW, Cocker DR, Berhane KT, HEI Health Review Committee. PMID: 22852485.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    76. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Ann Allergy Asthma Immunol. 2012 Jan; 108(1):49-53. Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I. PMID: 22192966.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    77. New therapeutics in C1INH deficiency: a review of recent studies and advances. Curr Allergy Asthma Rep. 2011 Aug; 11(4):300-8. Parikh N, Riedl MA. PMID: 21607669.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. Update on the acute treatment of hereditary angioedema. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):11-6. Riedl MA. PMID: 21262093.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Introduction: New Perspectives in Hereditary Angioedema (HAE): Molecular Mechanisms & Therapeutic Choices: A CME Symposium Presented at the 2009 World Allergy Congress, Buenos Aires, Argentina, December 9, 2009. World Allergy Organ J. 2010 Sep; 3(9 Suppl):S24. Zuraw BL, Frank MM, Riedl MA. PMID: 23282865; PMCID: PMC3666148.
      View in: PubMed   Mentions:
    80. Diagnosing and managing common food allergies: a systematic review. JAMA. 2010 May 12; 303(18):1848-56. Chafen JJ, Newberry SJ, Riedl MA, Bravata DM, Maglione M, Suttorp MJ, Sundaram V, Paige NM, Towfigh A, Hulley BJ, Shekelle PG. PMID: 20460624.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    81. Novel antioxidant approaches to the treatment of upper airway inflammation. Curr Opin Allergy Clin Immunol. 2010 Feb; 10(1):34-41. Braskett M, Riedl MA. PMID: 19935060.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    82. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin Immunol. 2009 Mar; 130(3):244-51. Riedl MA, Saxon A, Diaz-Sanchez D. PMID: 19028145; PMCID: PMC2668525.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    83. The effect of air pollution on asthma and allergy. Curr Allergy Asthma Rep. 2008 Apr; 8(2):139-46. Riedl MA. PMID: 18417056.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    84. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol. 2008 Feb; 8(1):49-56. Riedl MA, Nel AE. PMID: 18188018.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansAnimalsCells
    85. Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen. J Immunol. 2005 Jun 01; 174(11):7440-5. Riedl MA, Landaw EM, Saxon A, Diaz-Sanchez D. PMID: 15905593.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    86. Adverse drug reactions: types and treatment options. Am Fam Physician. 2003 Nov 01; 68(9):1781-90. Riedl MA, Casillas AM. PMID: 14620598.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    Marc's Networks
    Concepts (240)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version v3.1.0-868-g8ba5679c on PROFILES-PWEB02.

    Copyright © The Regents of the University of California